SHANGHAI, May 9, 2013 /PRNewswire/ -- ABACHEM is a public listed company in China, specializing in contract manufacturing to the pharmaceutical, biotechnological and agrochemical industries. Offering a broad spectrum of services for the production of fine chemicals, advanced intermediates, and APIs, ABACHEM have successfully collaborated and partnered with major pharmaceutical and agrochemical companies globally.
Our R&D department has over 80 scientists with solid industrial experience, providing process research and development services including process selection, optimization, and verification as well as reference standard and impurity preparations. Our laboratory is fully equipped with modern analytical instruments such as NMR, HPLC, UPLC, LC-MS, and GC-MS to ensure all projects are delivered with accuracy and a high degree of purity. DSC and ARSST are applied to every project to provide a reliable safety and hazard assessment.
ABACHEM promotes innovation and is open minded to new ideas and technologies. For example, development of technologies and processes for heterocyclic and asymmetric synthesis has been areas of long-term focus for the company. Heterocycles such as pyrazoles, triazoles, aza-indoles and unnatural amino acids manufactured based on processes developed in-house are some of the highlights. For chiral technology, besides the traditional asymmetric synthesis, we have recently enhanced our capability by establishing a biocatalysis group.
ABACHEM has tremendous manufacturing capability and capacity. Our four kilo-labs and five multi-functional pilot plants ensure a smooth tech-transfer from lab to commercial scale manufacturing. Through years of CMO business, the company has also accumulated invaluable knowledge and experience in persistent improvement of cost structure, hazardous material sourcing & handling, and regulatory filing including the latest New Chemicals Substance filing.
ABACHEM is continuously and actively improving its capabilities and capacity through new technologies & engineering as well as expansions to meet clients' outsourcing needs by offering cost-effective and time-efficient services and products. We have recently expanded our hydrogenation capacity significantly by installation of eighteen hydrogenation reactors ranging from 1000 to 5000L with two 1000L Hastelloy reactors to provide excellent material compatibility.
Founded in 2003, ABACHEM has developed into a public company with about 400 employees and over 1.2 million square feet of laboratory and manufacturing space. Currently, the company is headquartered in Shanghai with a R&D center in Zhangjiang Hi-Tech Park of Shanghai and three manufacturing facilities in Jiangsu province which are all within driving distance to Shanghai.
Tel: +86 13661842021